US FDA CTP checks itself to move forward in response to Reagan-Udall report

The US Food and Drug Administration (FDA) Center for Tobacco Products (CTP) has published a number of milestones to expect in the near term as it continues to address issues brought up by the Reagan-Udall Foundation’s recent report.

As part of this – and potentially for the first time – the FDA CTP acknowledged the role alternatives to traditional cigarettes could play in smoking cessation and said it wanted science to inform future public awareness campaigns.